A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study

2023/01/28 by Noah M. Hahn, Michael A. O'Donnell, Michael A. O’Donnell +45 · 1 citation
Immunology and Microbiology · Medicine · #Bladder and Urothelial Cancer Treatments #Immune responses and vaccinations #Urinary and Genital Oncology Studies

paper · doi:10.1016/j.eururo.2023.01.017

openalex publication_date 2023/01/28 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Citations

• EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Cited by

• A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non–muscle-invasive Bladder Cancer